• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Delivering Better Gut Health Supplements

    Delivering Dietary Supplements that Exceed Consumer Expectations

    Green Business Network Seeks Comment on New Certification for Hemp-CBD Businesses

    Sweeteners Market Continues to Broaden with Cleaner Labels and Better Formulations

    Optimizing Gut Health: Unlocking the Gates to Well-Being
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health

    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status

    Nutritional Complex Evidenced to Reduce Preterm Birth

    Meta-analysis Determines HMB Supplementation Promotes Healthy Muscle Mass in Older Adults

    AHPA’s 9th Botanical Congress to Take Place May 24
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health

    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status

    Nutritional Complex Evidenced to Reduce Preterm Birth

    Meta-analysis Determines HMB Supplementation Promotes Healthy Muscle Mass in Older Adults

    AHPA’s 9th Botanical Congress to Take Place May 24
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health

    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status

    Nutritional Complex Evidenced to Reduce Preterm Birth

    Meta-analysis Determines HMB Supplementation Promotes Healthy Muscle Mass in Older Adults

    AHPA’s 9th Botanical Congress to Take Place May 24
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health

    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status

    Nutritional Complex Evidenced to Reduce Preterm Birth

    Meta-analysis Determines HMB Supplementation Promotes Healthy Muscle Mass in Older Adults

    First Day Life Shuts Down Children's Behavioral, Cognitive Health Claims Following Challenge
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Nutrition21, LLC

    Sabinsa Corporation

    Verdure Sciences

    Gencor

    Chenland Nutritionals Inc.
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Chenland Nutritionals Inc.

    Vesta Nutra

    Bioenergy Life Science, Inc. (BLS)

    Indena USA, Inc.

    KLK OLEO - Davos Life Science
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    New Potential for Human Milk Oligosaccharides

    HMOs boost the immune system and protect against infections.

    New Potential for Human Milk Oligosaccharides
    By Ellen Kilger, PhD, Contributing Writer 06.02.20
    Our immune system helps us to avoid or overcome viral and bacterial infections. It features many interacting cells and molecules that ensure the body can recognize and fight intruders while distinguishing them from its own cells.

    The basis of a healthy immune system starts early in life and is influenced by genetics, the environment, and nutrition. Breast milk contains all the nutrients required for the growth and development of newborns, as well as components that help to establish a healthy immune system and a balanced microbiome to protect against disease. This is why breastfeeding is considered the “gold standard” of infant nutrition. Many of the components of breast milk that support the immune system and inhibit pathogens are complex sugar molecules known as human milk oligosaccharides (HMOs).

    Sugars with Diverse Structures & Functions
    The rich repertoire of HMOs has evolved over millions of years. Synthesized in the mammary gland, they are based on lactose, a disaccharide of glucose and galactose units, to which one or more monosaccharides are linked in a variety of combinations. HMOs contain one or more of the five principal building blocks: glucose, galactose, N-acetylglucosamine, fucose, and sialic acid.

    More than 200 different HMO molecules have been identified, and every mother has a unique set of HMOs in her milk, depending on genetics and environmental factors. For example, the most abundant oligosaccharide in human milk is usually 2’-fucosyllactose (2’-FL) but it is produced by only 80% of mothers (those with the “secretor” blood type).

    Early Life Sets the Stage for a Healthy Immune System
    A balanced community of microorganisms in the gut (the gut microbiome) is now recognized as a major contributor to good health. In contrast, dysbiosis of the gut microbiome is associated with several diseases, including obesity, diabetes, inflammatory bowel disease, asthma, allergies, cancer, and even neurological and behavioral disorders.1

    Breastfeeding is the most significant factor associated with microbiome composition in early life, promoting the accumulation of beneficial bacteria from the genus Bifidobacterium, as highlighted in a recent study published in Nature.2 The study found the first year of life is a key phase of microbiome development, with breastmilk being the main factor that influences microbiome composition during this time. The study characterized the microbiome of 903 children 3 to 46 months of age by sequencing the 16S rRNA gene, which is a rapid way to determine the diversity and quantity of different bacterial species.

    The immune system also develops during this neonatal phase, coincident with bacterial colonization of the intestine and the maturation of the gut epithelium and its mucosal layer.3 This early priming has been described as a window of opportunity to emphasize the exclusive and non-redundant functions of the early postnatal and infant period for the establishment of lifelong homeostasis.4 The disruption of this critical phase may increase the risk of various autoimmune and inflammatory diseases later in life.

    HMOs as Prebiotics
    One of the important functions of HMOs is to provide nutrients for beneficial bacteria during the establishment of the microbiome and the development of the immune system. These complex sugars are not digested by the infant and therefore reach the colon intact. Here, they are fermented by intestinal bacteria such as those of the genera Bifidobacterium and Bacteroides, which produce enzymes for the utilization of HMOs. In this way, HMOs act as prebiotics to promote the growth of beneficial bacteria, outcompeting harmful bacteria and helping to shape the infant’s microbiome. Interactions between the microbiome, gastrointestinal tract and immune system early in life are needed to train the immune system so that it can tolerate food, recognize and ignore beneficial microbes, and respond appropriately to pathogens.4-5

    When infants are not breastfed, and receive infant formula without HMOs instead, the emerging microbiome is different, with fewer Bifidobacteria than found in breastfed children.6 This can increase the risk of infections, leading to higher rates of diarrhea during infancy but also a greater prevalence of immunity-related and inflammatory diseases later in life.1

    Protection Against Microbial Infections
    In addition to their prebiotic effects, HMOs also confer direct protection against pathogens by acting as decoys.3 Bacteria and viruses cannot cause infections without first binding to their target cells, and this usually requires a protein on the pathogen to interact with a glycoprotein projecting from the surface of the host cell, such as an epithelial cell lining the gut. Some HMOs can act as soluble decoy receptors by mimicking these glycoprotein landing sites, thus coating harmful bacteria, viruses, and toxins and carrying them through the gut before they can interact with any cells.

    For example, fucosylated HMOs (including 2’-FL) can bind to Campylobacter jejuni, one of the most common causes of bacterial diarrhea in humans. This stops the bacterium binding to its actual receptor on the gut epithelium. A cohort study found that the incidence of Campylobacter diarrhea in breastfed infants was inversely associated with the amount of 2’-FL in the mother’s breastmilk.7

    Similarly, HMOs also protect infants against noroviruses, the most common cause of acute viral gastroenteritis in the world. The virus infects people of all ages, is easily transmitted, and leads to diarrhea, vomiting, and stomach cramps. Norovirus binds to histo-blood group antigens (HBGAs) on epithelial cells. Fucosylated HMOs, which resemble HBGA structures, bind to noroviruses and coat them in a sugar layer that blocks their ability to make contact with cells.8 Both 2’-FL and 3-FL can block norovirus binding to HBGA samples in vitro, so further research could facilitate the development of fucosylated HMOs as an antiviral therapy to fight norovirus infections in the future.9

    Other in vitro studies found that different HMOs inhibited the adhesion of enteropathogenic Escherichia coli (EPEC), Haemophilus influenzae, Streptococcus pneumoniae, and Salmonella fyris to epithelial cells, and 2’-FL and 3-FL inhibited the adhesion of Pseudomonas aeruginosa, a major cause of pneumonia, to respiratory epithelial cells. Some HMOs also neutralize bacterial toxins, such as the diarrhea-causing enterotoxins produced by Clostridium difficile.10 Given the diverse HMO structures in human milk, many different anti-infective properties are likely to await discovery.

    HMOs as Dietary Supplements
    Breastfeeding is the gold standard of infant nutrition, but some mothers cannot produce sufficient quantities of milk and others elect not to breastfeed. These mothers rely on infant formula, which generally provides the essential nutrients for their baby’s growth and development but lacks the important health benefits of HMOs. However, some HMOs are now produced on a large scale using biotechnology, and this has paved the way to include them as infant formula supplements.

    One of the first companies to use bacterial fermentation for the production of HMOs was Jennewein Biotechnologie GmbH. Jennewein initially focused on the production of 2’-FL because it is the most abundant HMO produced by most mothers and has many benefits, as discussed above. Jennewein 2’-FL was approved as a dietary ingredient by the FDA in 2015, and as a Novel Food in Europe in 2017. Today, several infant formulae on the market contain Jennewein 2’-FL. “This is a first step to bring the health benefits of HMOs to children who are not, or not exclusively, breastfed,” said Katja Parschat, deputy head of research and development at Jennewein Biotechnologie GmbH.

    The company’s aim is to supplement infant food with additional HMOs, thus achieving even more benefits. “We have now produced the five most common HMOs,” Parschat explained, “and we have developed a mixture with all five in the ratio representing their average natural concentrations.”

    The new 5-HMO Mix contains 2’-FL, 3-FL, lacto-N-tetraose, 3’-sialyllactose, and 6’-sialyllactose. “It represents compounds of the entire spectrum of neutral, neutral-fucosylated and sialylated HMOs, and adding several different HMOs may be more beneficial than just one, not only because their positive effects are combined but also because they may have synergistic effects,” Parschat said. The tolerability of the mixture is currently being tested in a growth and tolerance study involving 324 babies. Researchers will also investigate its effects on the infant microbiome.

    Another clinical study has already shown that infants fed with formula containing 2’-FL and lacto-N-neotetraose had significantly fewer parental reports of bronchitis, a lower incidence of lower respiratory tract infections, less use of antipyretics and antibiotics, and protective effects that continued well beyond the 6-month intervention period.11

    Potential for New Therapies
    The immense potential of HMOs for human health has encouraged significant advances in research and development recently, with several companies now producing HMOs as dietary/food supplements for infant nutrition. In the future, the positive effects of HMOs could be extended beyond infant nutrition products in order to help adults rebalance their microbiome and regain their health.

    “We think there are opportunities for people of all ages,” said Prof. Lars Bode, director of the Mother-Milk-Infant Center of Research Excellence (MOMI) at University of California San Diego (UCSD), who is developing novel therapies from milk components. According to Bode, the potential antiviral effects of HMOs have come into sharp focus during the COVID-19 pandemic, and he has teamed up with virology experts from UCSD to develop new antivirals from human milk that might help to prevent or treat this disease.12

    To address the effects of lifelong diseases mediated by the immune system, inflammation or chronic metabolic disorders, researchers are seeking ways to support and maintain a healthy microbiome. Given the importance of early-life events, promoting breastfeeding as the best choice for infants and, where this is not possible, using HMOs as infant formula supplements, may be a promising way to achieve this goal. Research to unravel the diversity and full potential of HMOs is therefore likely to reveal many new insights and products in the future.

    About the Author: Ellen Kilger is a German science journalist specializing in biomedicine and life sciences. She is particularly interested in research on age-related diseases and the influence of genetics, nutrition, microbiome, and the immune system on disease development.

    References
    1. Ximenez C and Torres J (2017) Development of Microbiota in Infants and its Role in Maturation of Gut Mucosa and Immune System. Arch Med Res. 48(8):666-680. https://doi.org/10.1016/j.arcmed.2017.11.007
    2. Stewart CJ, Ajami NJ, O’Brien JL, et al. (2018) Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature 562, 583–588. https://doi.org/10.1038/s41586-018-0617-x
    3. Ayechu-Muruzabal V, van Stigt AH, Mank M, et al. (2018) Diversity of human milk oligosaccharides and effects on early life immune development. Front Pediatr 6, 239. https://doi.org/10.3389/fped.2018.00239
    4. Torow N and Hornef MW (2017) The neonatal window of opportunity: setting the stage for life-long host-microbial interaction and immune homeostasis. J Immunol 198, 557–563. https://doi.org/10.4049/jimmunol.1601253
    5. Moossavi S, Miliku K, Sepehri S, et al. (2018) The prebiotic and probiotic properties of human milk: implications for infant immune development and pediatric asthma. Front Pediatr 6, 197. https://doi.org/10.3389/fped.2018.00197
    6. Ho NT, Li F, Lee-Sarwar KA, et al. (2018) Meta-analysis of effects of exclusive breastfeeding on infant gut microbiota across populations. Nat Comm. 9(1):4169. https://doi.org/10.1038/s41467-018-06473-x
    7. Triantis V, Bode L, van Neerven RJJ (2018) Immunological effects of human milk oligosaccharides. Front Pediatr 6, 190. https://doi.org/10.3389/fped.2018.00190
    8. Krammer EM and Bouckaert JM (2018) Norovirus devours human milk oligosaccharides rich in α-fucose. J Biol Chem  293, 11966–11967. https://doi.org/10.1074/jbc.H118.004336
    9. Weichert S, Koromyslova A, Singh BK, et al. (2016) Structural basis for norovirus inhibition by human milk oligosaccharides. J Virol 90, 4843–4848. https://doi.org/10.1128/JVI.03223-15
    10. Craft, KM and Townsend SD (2018) The human milk glycome as a defense against infectious diseases: rationale, challenges, and opportunities. ACS Infect. Dis. 4, 2, 77-83. https://doi.org/10.1021/acsinfecdis.7b00209
    11. Puccio G, Alliet P, Caiozzo C, et al. (2017) Effects of infant formula with human milk oligosaccharides on growth and morbidity: a randomized multicenter trial. J Pediatr Gastroenterol Nutr 64, 624–631. https://doi.org/10.1097/MPG.0000000000001520
    12. Prof. Lars Bode, University of California Television (UCTV), 28.04.2020 https://www.youtube.com/watch?v=x1sFEcd3wFM
    Related Searches
    • Digestive Health
    • Research
    • Infant & Children's Health
    • Probiotics & Prebiotics
    Related Knowledge Center
    • Infant & Children's Health
    • Digestive Health
    • Probiotics & Prebiotics

    Related Features

    • Cognitive Function | Dietary Supplements | Digestive Health | Enzymes | Fiber & Carbohydrates | Healthcare Trends | Immune Function | Probiotics & Prebiotics | Research
      Optimizing Gut Health: Unlocking the Gates to Well-Being

      Optimizing Gut Health: Unlocking the Gates to Well-Being

      Tied to so many facets of wellness, the gut microbiome will continue to be an attractive target for nutritional products.
      By Sean Moloughney, Editor 04.08.21

    • Consumer Trends | Delivery & Dosage Technologies | Dietary Supplements | Natural/Organic | Omega-3s
      Delivering Dietary Supplements that Exceed Consumer Expectations

      Delivering Dietary Supplements that Exceed Consumer Expectations

      Sophisticated and innovative dosage formats can help position brands for success.
      By Sean Moloughney, Editor 04.08.21

    • Delivery & Dosage Technologies | Dietary Supplements | Probiotics & Prebiotics | Quality & Safety
      Delivering Better Gut Health Supplements

      Delivering Better Gut Health Supplements

      Processing controls for raw materials, manufacturing, consumer packaging and more will help ensure best-in-class product performance.
      By Scott Steinford, CEO, Health Wright Products 04.08.21


    • Consumer Trends | Delivery & Dosage Technologies | Healthcare Trends | Herbs & Botanicals
      Global Cannabis Sales Surpass $21 Billion in 2020

      Global Cannabis Sales Surpass $21 Billion in 2020

      Market news in the CBD industry.
      By Sean Moloughney, Editor 04.01.21

    • Cosmeceuticals / Nutricosmetics | Delivery & Dosage Technologies | Healthcare Trends | Herbs & Botanicals
      Is Cannabidiol Coming to Your City or Hamlet?

      Is Cannabidiol Coming to Your City or Hamlet?

      CBD is the talk of the town these days. But before formulators take part in all of this madness, there are many questions to be answered.
      By Jules Zecchino, Simply Active Cosmetics, Inc. 04.01.21

    • Cosmeceuticals / Nutricosmetics | Delivery & Dosage Technologies | Healthcare Trends | Herbs & Botanicals | Quality & Safety | Regulations
      The Cannabis Glow Up

      The Cannabis Glow Up

      The notorious plant rises from its troubled history to provide new possibilities in cosmetics.
      By Nicole Foss, MBA, MSN, RN, NeXtraction 04.01.21


    • Delivery & Dosage Technologies | Herbs & Botanicals | Research
      Supporting CBD Science: The Path to Claims

      Supporting CBD Science: The Path to Claims

      Pharmacokinetics study showed Caliper CBD products absorbed faster than CBD oil and isolate.
      By Keith Woelfel, Director of R&D, Caliper Foods 04.01.21

    • Consumer Trends | Dietary Supplements | Healthcare Trends | Healthy Aging | Immune Function | Research
      Personalized Nutrition: Science & Innovation Bring Concept to Life

      Personalized Nutrition: Science & Innovation Bring Concept to Life

      This rapidly developing field could be positioned to catalyze a new health paradigm.
      By Sean Moloughney, Editor 03.03.21

    • Consumer Trends | Delivery & Dosage Technologies | Dietary Supplements | Healthcare Trends | Healthy Aging | Nutrition Bars & Snacks | Proteins, Peptides, Amino Acids | Sports Nutrition | Weight Management/Weight Loss
      Following the Ascent of Alternative Proteins

      Following the Ascent of Alternative Proteins

      As the protein palate of global consumers turns greener, concerted efforts to create nutritionally optimized, appealing options abound.
      By Mike Montemarano, Associate Editor 03.03.21


    • Consumer Trends | Delivery & Dosage Technologies | Dietary Supplements | Healthcare Trends | Healthy Aging | Proteins, Peptides, Amino Acids | Research | Sports Nutrition
      Performance, Personalization Continue Driving the Market for Stalwart Protein Supplements

      Performance, Personalization Continue Driving the Market for Stalwart Protein Supplements

      As the line between athletes and active consumers continues to blur, a growing number of protein supplement users seek clean, powerful, and personal solutions.
      By Mike Montemarano, Associate Editor 03.03.21

    • Delivery & Dosage Technologies | Dietary Supplements | Healthcare Trends
      Advancements in Liquid Fill Technology

      Advancements in Liquid Fill Technology

      Hard capsule liquid fill technology offers brands the ability to develop products with enhanced bioavailability that are more user-friendly and convenient.
      By Dr. Jnanadeva Bhat and Anita Solanki, ACG Group 03.03.21

    • Delivery & Dosage Technologies | Dietary Supplements | Healthcare Trends | Marine Nutraceuticals | Proteins, Peptides, Amino Acids
      Aker BioMarine Launches Krill-Derived Protein Ingredient, INVI

      Aker BioMarine Launches Krill-Derived Protein Ingredient, INVI

      A biomass of krill off the Antarctic coast provides a novel, sustainable source of dense, high-quality protein.
      By Mike Montemarano, Associate Editor 03.03.21


    • Contract Manufacturing | Delivery & Dosage Technologies | Dietary Supplements
      2021 Contract Manufacturing Survey

      2021 Contract Manufacturing Survey

      Our fourth annual audience poll indicates continued reliance on manufacturing partners, particularly for small businesses.
      By Sean Moloughney, Editor, Nutraceuticals World 03.03.21

    • Contract Manufacturing | Delivery & Dosage Technologies | Dietary Supplements | Functional Foods & Beverages | Healthcare Trends | Quality & Safety | Testing
      Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow

      Nutraceutical Manufacturing: Meeting the Challenges of Today, Planning for Tomorrow

      Companies continue balancing high demand, supply disruption, and worker safety during the pandemic.
      By Sean Moloughney, Editor, Nutraceuticals World 03.03.21

    • Contract Manufacturing | Delivery & Dosage Technologies
      Oral Solids: Market & Technology Trends

      Oral Solids: Market & Technology Trends

      Oral solids remain the preferred route of drug delivery due to their cost-effectiveness, ease of manufacturing, and patient-friendly dose form options.
      By Tim Wright, Editor, Contract Pharma 03.03.21

    Trending
    • NSF/Harvard Study Finds Deterenol, Other Stimulants In Sports & Weight Loss Supplements
    • Several Studies Evaluate Role Of Vitamin D In COVID-19 Outcomes
    • Study Investigates Probiotics Impact On COVID-19 Remission Rates
    • Focus, Endurance, Resilience: The Esports Community Is Seeking Out Supplements
    • New Study Confirms Vegan Vitamin D3 Ingredient Is Bioavailable
    Breaking News
    • Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health
    • CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status
    • Nutritional Complex Evidenced to Reduce Preterm Birth
    • Meta-analysis Determines HMB Supplementation Promotes Healthy Muscle Mass in Older Adults
    • AHPA’s 9th Botanical Congress to Take Place May 24
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Optimizing Gut Health: Unlocking the Gates to Well-Being
    • Sweeteners Market Continues to Broaden with Cleaner Labels and Better Formulations
    • Green Business Network Seeks Comment on New Certification for Hemp-CBD Businesses
    • Delivering Dietary Supplements that Exceed Consumer Expectations
    • Delivering Better Gut Health Supplements
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health
    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status
    Nutritional Complex Evidenced to Reduce Preterm Birth
    Coatings World

    Latest Breaking News From Coatings World

    Chromaflo Technologies to Sponsor and Exhibit at the North American Pultrusion Conference 2021
    Barentz Expands Canadian CASE Team
    Shepherd Color Company Opens Sales Office in China
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CMS Establishes New Payment for Pelvalon’s Eclipse System
    Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy
    Resonetics Leases New Manufacturing Space in Costa Rica
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    Ascendia Pharmaceuticals Poised for Expansion
    Bora Pharmaceuticals Adds Roller Compaction Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Revlon Unveils New Fragrances Featuring Megan Thee Stallion & Sofia Carson
    Henkel Management Board Welcomes Wolfgang König
    Mielle Organics Gets a Major Investment
    Happi

    Latest Breaking News From Happi

    Nature’s Beauty Debuts Vegan Natural Body Care at Walgreens
    Estée Lauder Expands Beautiful Fragrance Collection
    The Honest Company Files for IPO
    Ink World

    Latest Breaking News From Ink World

    SE-DA Invests in Kornit Presto S
    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    Iron Oxide Pigments Market to Register 4.7% CAGR from 2021 to 2028: GVR
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Dantex elevates Joseph Sanchez to digital business development manager
    Mactac's Kevin Clunie joins TLMI panel
    MacDermid announces two new global sales roles
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Precision Textiles Offers Biodegradable Medical Fabric
    Northshore Launches Megamax Briefs in New Colors
    Essity Acquires Distribution Rights to Sorbact in Australia and New Zealand
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    Google Executive Joins SeaSpine's Board of Directors
    HSS and LimaCorporate Open Provider-Based 3D Design and Printing Facility
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Tive Multi-sensor Tracker Solo 5G Relies on Sensirion SHT33
    VTT in 2020: Successful Year Despite Globally Challenging Times
    Lux Research: 3D Printing Market to Reach $51 Billion in 2030

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login